Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B | 9 | 2023 | 339 | 1.800 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2016 | 149 | 1.730 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2016 | 356 | 1.440 |
Why?
|
| Sesquiterpenes | 3 | 2013 | 32 | 1.240 |
Why?
|
| Streptomyces | 3 | 2014 | 16 | 1.180 |
Why?
|
| Withanolides | 3 | 2016 | 9 | 1.130 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 352 | 1.030 |
Why?
|
| Plant Extracts | 10 | 2016 | 286 | 0.990 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 4 | 0.910 |
Why?
|
| Lactones | 2 | 2013 | 22 | 0.890 |
Why?
|
| Vernonia | 2 | 2013 | 15 | 0.890 |
Why?
|
| Molecular Structure | 13 | 2018 | 492 | 0.880 |
Why?
|
| Plants, Medicinal | 5 | 2010 | 68 | 0.850 |
Why?
|
| Lipopolysaccharides | 5 | 2023 | 220 | 0.820 |
Why?
|
| Nitric Oxide | 7 | 2016 | 316 | 0.810 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2016 | 16 | 0.710 |
Why?
|
| Physalis | 2 | 2016 | 3 | 0.700 |
Why?
|
| STAT3 Transcription Factor | 3 | 2024 | 90 | 0.690 |
Why?
|
| Gardenia | 1 | 2016 | 1 | 0.570 |
Why?
|
| Triterpenes | 1 | 2016 | 14 | 0.560 |
Why?
|
| Disaccharidases | 1 | 2016 | 1 | 0.560 |
Why?
|
| Levivirus | 1 | 2016 | 1 | 0.560 |
Why?
|
| Morinda | 1 | 2016 | 9 | 0.560 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2018 | 201 | 0.550 |
Why?
|
| Structure-Activity Relationship | 8 | 2018 | 409 | 0.550 |
Why?
|
| Chaetomium | 1 | 2015 | 2 | 0.530 |
Why?
|
| Benzopyrans | 1 | 2015 | 14 | 0.530 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 121 | 0.510 |
Why?
|
| Mice | 13 | 2024 | 5913 | 0.480 |
Why?
|
| Drug Resistance, Microbial | 1 | 2014 | 26 | 0.480 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 202 | 0.470 |
Why?
|
| Purine Nucleosides | 1 | 2014 | 14 | 0.470 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 145 | 0.470 |
Why?
|
| Peptide Fragments | 1 | 2016 | 308 | 0.470 |
Why?
|
| Moringa oleifera | 2 | 2011 | 2 | 0.470 |
Why?
|
| Carbazoles | 1 | 2014 | 42 | 0.470 |
Why?
|
| Sulfonamides | 1 | 2014 | 80 | 0.460 |
Why?
|
| Withania | 1 | 2013 | 5 | 0.440 |
Why?
|
| Indoles | 1 | 2014 | 158 | 0.430 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2013 | 110 | 0.430 |
Why?
|
| Aminocoumarins | 1 | 2010 | 1 | 0.370 |
Why?
|
| Novobiocin | 1 | 2010 | 2 | 0.370 |
Why?
|
| Cell Line | 5 | 2016 | 1354 | 0.370 |
Why?
|
| Animals | 16 | 2024 | 15081 | 0.370 |
Why?
|
| Porifera | 1 | 2010 | 8 | 0.360 |
Why?
|
| Glycosides | 1 | 2010 | 21 | 0.360 |
Why?
|
| Peroxides | 1 | 2010 | 20 | 0.360 |
Why?
|
| Macrophages | 2 | 2013 | 439 | 0.360 |
Why?
|
| Imides | 1 | 2009 | 9 | 0.350 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 32 | 0.340 |
Why?
|
| Phytotherapy | 2 | 2007 | 81 | 0.340 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2014 | 84 | 0.310 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 206 | 0.310 |
Why?
|
| Mycobacterium marinum | 1 | 2007 | 7 | 0.300 |
Why?
|
| Apoptosis | 3 | 2023 | 1398 | 0.290 |
Why?
|
| Isothiocyanates | 4 | 2023 | 18 | 0.290 |
Why?
|
| Models, Molecular | 3 | 2016 | 808 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 1039 | 0.280 |
Why?
|
| Humans | 18 | 2024 | 37093 | 0.280 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2015 | 289 | 0.270 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2018 | 56 | 0.260 |
Why?
|
| Molecular Conformation | 2 | 2016 | 152 | 0.260 |
Why?
|
| Dextran Sulfate | 1 | 2024 | 15 | 0.240 |
Why?
|
| Nitro Compounds | 1 | 2024 | 33 | 0.240 |
Why?
|
| Thiazoles | 1 | 2024 | 74 | 0.230 |
Why?
|
| Moths | 1 | 2023 | 10 | 0.230 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 54 | 0.230 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 265 | 0.230 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 122 | 0.220 |
Why?
|
| Aldehydes | 1 | 2023 | 69 | 0.220 |
Why?
|
| Hepatocytes | 1 | 2023 | 75 | 0.220 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 62 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 502 | 0.210 |
Why?
|
| Biological Factors | 1 | 2000 | 6 | 0.190 |
Why?
|
| Trees | 1 | 2000 | 19 | 0.190 |
Why?
|
| Quinolones | 1 | 2018 | 7 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2013 | 113 | 0.160 |
Why?
|
| Mice, Nude | 2 | 2016 | 337 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 259 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2024 | 115 | 0.150 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 58 | 0.150 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 28 | 0.150 |
Why?
|
| Triazoles | 1 | 2017 | 86 | 0.140 |
Why?
|
| Tuberculosis | 1 | 2017 | 63 | 0.140 |
Why?
|
| Iridoids | 1 | 2016 | 5 | 0.140 |
Why?
|
| Fermentation | 1 | 2016 | 26 | 0.140 |
Why?
|
| Histone Code | 1 | 2016 | 13 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 90 | 0.140 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2016 | 47 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2016 | 158 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 2 | 2016 | 104 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2016 | 127 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2016 | 125 | 0.130 |
Why?
|
| Hedera | 1 | 2014 | 1 | 0.120 |
Why?
|
| Zygophyllaceae | 1 | 2014 | 2 | 0.120 |
Why?
|
| Glioma | 1 | 2015 | 79 | 0.120 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2014 | 4 | 0.120 |
Why?
|
| Semaphorins | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fruit | 1 | 2016 | 173 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2016 | 326 | 0.120 |
Why?
|
| Arabinonucleosides | 1 | 2014 | 2 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 661 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 111 | 0.120 |
Why?
|
| Hemolysis | 1 | 2014 | 40 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 65 | 0.120 |
Why?
|
| Keratin-8 | 1 | 2013 | 2 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 515 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 190 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2014 | 82 | 0.110 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 132 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 2231 | 0.110 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 57 | 0.110 |
Why?
|
| Hela Cells | 1 | 2014 | 366 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 160 | 0.110 |
Why?
|
| Flowers | 1 | 2012 | 16 | 0.110 |
Why?
|
| Rhamnose | 1 | 2011 | 2 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 435 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 803 | 0.100 |
Why?
|
| Caco-2 Cells | 2 | 2024 | 52 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 807 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1198 | 0.090 |
Why?
|
| Yeasts | 1 | 2010 | 19 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 83 | 0.090 |
Why?
|
| Thiadiazoles | 1 | 2009 | 4 | 0.090 |
Why?
|
| Phenols | 1 | 2010 | 80 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 935 | 0.080 |
Why?
|
| Neoplasms | 2 | 2012 | 1103 | 0.080 |
Why?
|
| Plants | 2 | 2023 | 99 | 0.080 |
Why?
|
| Seawater | 1 | 2007 | 45 | 0.070 |
Why?
|
| Female | 4 | 2023 | 20969 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 32 | 0.060 |
Why?
|
| Anticarcinogenic Agents | 1 | 2004 | 65 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2024 | 58 | 0.060 |
Why?
|
| Colon | 1 | 2024 | 103 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2024 | 153 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2023 | 81 | 0.060 |
Why?
|
| Brucea | 1 | 2002 | 1 | 0.050 |
Why?
|
| Pyrans | 1 | 2002 | 10 | 0.050 |
Why?
|
| Seeds | 1 | 2002 | 35 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 92 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2024 | 1908 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 618 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 1609 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 1371 | 0.040 |
Why?
|
| Thiocyanates | 1 | 1997 | 7 | 0.040 |
Why?
|
| Sulfoxides | 1 | 1997 | 16 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1997 | 53 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1997 | 23 | 0.040 |
Why?
|
| India | 1 | 1997 | 88 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1997 | 98 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2016 | 35 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2016 | 45 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 55 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 32 | 0.030 |
Why?
|
| HSP110 Heat-Shock Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2015 | 1 | 0.030 |
Why?
|
| alpha Karyopherins | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Vimentin | 1 | 2015 | 37 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 112 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 85 | 0.030 |
Why?
|
| Histones | 1 | 2016 | 190 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2014 | 23 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2015 | 174 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 366 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 448 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 286 | 0.030 |
Why?
|
| Base Sequence | 1 | 2013 | 997 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 93 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 859 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 136 | 0.020 |
Why?
|
| Male | 2 | 2024 | 20025 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 168 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 433 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 928 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 4268 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 103 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 587 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 11712 | 0.010 |
Why?
|